EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Total Debt (2011 - 2023)

EyePoint (EYPT) posted Total Debt of $34.7 million for Q1 2023, down 12.87% sequentially from $39.8 million in Q4 2022, and down 12.42% YoY from $39.6 million in Q1 2022.

Analysis

EyePoint (EYPT) Total Debt (2011 - 2023) Analysis & Trends

EyePoint has reported Total Debt for 6 years, with the latest figure at $34.7 million in Q1 2023.

  • Quarterly Total Debt fell 12.42% year-over-year to $34.7 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $34.7 million (down 12.42% YoY) and the FY2022 annual result came in at $39.8 million, up 8.82% from the prior year.
  • Total Debt retreated to $34.7 million in Q1 2023 per EYPT's latest filing, from $39.8 million in the prior quarter.
  • Over five years, Total Debt peaked at $50.8 million in Q3 2020 and troughed at $32.0 million in Q1 2019.
  • A 5-year average of $41.2 million and a median of $39.7 million in 2022 frame the typical range for Total Debt.
  • The sharpest annual moves came in 2019 and 2021: Total Debt jumped 167.99% in 2019, then retreated 28.32% in 2021.
  • Over 5 years, Total Debt stood at $47.2 million in 2019, then declined by 19.58% to $38.0 million in 2020, then dropped by 3.73% to $36.6 million in 2021, then gained by 8.82% to $39.8 million in 2022, then slipped by 12.87% to $34.7 million in 2023.
  • According to Business Quant data, Total Debt over the past three periods registered $34.7 million, $39.8 million, and $39.7 million for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 591.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.07 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.34 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 546.77 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 39.96 Mn
Dec 31, 2022 50.26 Mn
Sep 30, 2022 50.20 Mn
Jun 30, 2022 50.13 Mn
Mar 31, 2022 50.06 Mn
Dec 31, 2021 36.56 Mn
Sep 30, 2021 36.40 Mn
Jun 30, 2021 36.24 Mn
Mar 31, 2021 38.12 Mn
Dec 31, 2020 37.98 Mn
Sep 30, 2020 50.78 Mn
Jun 30, 2020 50.26 Mn
Mar 31, 2020 47.72 Mn
Dec 31, 2019 47.22 Mn
Sep 30, 2019 46.73 Mn
Jun 30, 2019 46.25 Mn
Mar 31, 2019 31.95 Mn
Dec 31, 2018 17.62 Mn
Sep 30, 2018 17.46 Mn
Jun 30, 2018 17.31 Mn